Description
MLN 2480(BIIB-024) is an oral, selective pan-Raf kinase inhibitor in clinical trials.
MLN 2480(BIIB-024) is an oral, selective pan-Raf kinase inhibitor in clinical trials.
Alternate Name/Synonyms: MLN2480; ML-N2480; ML N2480; BIIB-024; BIIB024; BIIB 024; TAK-58; TAK580; TAK 580; AMG 2112819; AMG-2112819; AMG2112819; (R)-2-(1-(6-amino-5-chloropyrimidine-4-carboxamido)ethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide; 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5-chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide
Appearance: Solid
Formulation: N/A
CAS Number: 1096708-71-2
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₁₇H₁₂Cl₂F₃N₇O₂S
Molecular Weight: 506.29
Cell-Permeable?: Yes
Purity: >98%
Solubilities: DMSO
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A selective pan-Raf kinase inhibitor
MDL Number: MFCD22571730
PubChem CID: 25161177
SMILES: CC(C1=NC=C(S1)C(=O)NC2=NC=C(C(=C2)C(F)(F)F)Cl)NC(=O)C3=C(C(=NC=N3)N)Cl
InChi: InChI=1S/C17H12Cl2F3N7O2S/c1-6(28-15(31)12-11(19)13(23)27-5-26-12)16-25-4-9(32-16)14(30)29-10-2-7(17(20,21)22)8(18)3-24-10/h2-6H,1H3,(H,28,31)(H2,23,26,27)(H,24,29,30)/t6-/m1/s1
InChi Key: VWMJHAFYPMOMGF-ZCFIWIBFSA-N
Additional Information
Storage Condition: |
-20°C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |